Free Trial
NASDAQ:IZTC

Invizyne Technologies (IZTC) Stock Price, News & Analysis

Invizyne Technologies logo
$12.05 -1.48 (-10.94%)
As of 04/24/2025

About Invizyne Technologies Stock (NASDAQ:IZTC)

Key Stats

Today's Range
$11.56
$14.31
50-Day Range
$9.95
$19.42
52-Week Range
$8.50
$23.00
Volume
29,112 shs
Average Volume
37,647 shs
Market Capitalization
$75.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Receive IZTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invizyne Technologies and its competitors with MarketBeat's FREE daily newsletter.

IZTC Stock News Headlines

[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Invizyne announces corporate name change to eXoZymes
Invizyne Technologies Inc trading resumes
Invizyne Technologies Inc trading halted, volatility trading pause
See More Headlines

IZTC Stock Analysis - Frequently Asked Questions

Invizyne Technologies' stock was trading at $16.50 at the beginning of the year. Since then, IZTC shares have decreased by 27.0% and is now trading at $12.05.
View the best growth stocks for 2025 here
.

Invizyne Technologies (IZTC) raised $15 million in an initial public offering on Wednesday, November 13th 2024. The company issued 1,875,000 shares at $8.00 per share.

Invizyne Technologies' lock-up period expires on Monday, May 12th. Invizyne Technologies had issued 1,875,000 shares in its public offering on November 13th. The total size of the offering was $15,000,000 based on an initial share price of $8.00. After the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Shares of IZTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IZTC
Previous Symbol
NASDAQ:IZTC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$84.59 million
Optionable
N/A
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:IZTC) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners